Z-2894-2026 Class II Ongoing

Recalled by Aniara Diagnostica LLC — West Chester, OH

FDA device recall Z-2894-2026 was initiated by Aniara Diagnostica LLC on Jul 1, 2026 and is designated Class II. Reason for recall: Stability issues with the reconstituted lyophilized human plasma and bivalirudin matrix have been identified. These stability issues lead to a degradation of measurable bivalirudin in the controls… The recall status is ongoing. Affected quantity: 4 units.

Recall details

Product Type
Devices
Report Date
Aug 12, 2026
Initiation Date
Jul 1, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4 units

Product description

5-PLASMA Bivalirudin AMR Verification Kit, Model Number 5D-45905

Reason for recall

Stability issues with the reconstituted lyophilized human plasma and bivalirudin matrix have been identified. These stability issues lead to a degradation of measurable bivalirudin in the controls, calibrators, and linearity values.

Distribution pattern

US Nationwide distribution in the states of IL, NC, TN.

Code information

UDI-DI: 05070002420378, Lot Number: KE132603

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2894-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2894-2026. Report a data issue: hello@regdatalab.com.